Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Free Cash Flow: -170.60M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -170.60M |
| December 31, 2023 | -150.08M |
| September 30, 2023 | -144.01M |
| June 30, 2023 | -127.12M |
| March 31, 2023 | -114.33M |
| December 31, 2022 | -109.90M |
| September 30, 2022 | -87.76M |
| Date | Value |
|---|---|
| June 30, 2022 | -76.76M |
| March 31, 2022 | -60.37M |
| December 31, 2021 | -56.54M |
| September 30, 2021 | -49.31M |
| June 30, 2021 | -40.66M |
| March 31, 2021 | -29.15M |
| December 31, 2020 | -13.58M |
Free Cash Flow Range, Past 5 Years
-170.60M
Minimum
Mar 2024
-13.58M
Maximum
Dec 2020
-87.87M
Average
-82.26M
Median
Free Cash Flow Benchmarks
| Revolution Medicines Inc | -457.88M |
| Zentalis Pharmaceuticals Inc | -211.14M |
| Perspective Therapeutics Inc | -23.28M |
| Electromed Inc | 4.787M |
| Xtant Medical Holdings Inc | -14.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -49.73M |
| Cash from Investing (Quarterly) | 89.29M |
| Cash from Financing (Quarterly) | 0.048M |
| Free Cash Flow Per Share (Quarterly) | -0.5737 |
| Free Cash Flow Yield | -12.65% |